The pharmaceutical and biotech industries are no stranger to litigation. Dan Silver reviews recent litigation trends and significant cases impacting the industry and discuss what may be on the horizon. Session topics include Hatch-Waxman, BPCIA, 340B, and the impact of the Inflation Reduction Act.
10.18.2023